T Rispens Selected Research

T Rispens Research Topics

7	Rheumatoid Arthritis 03/2022 - 02/2015
4	Multiple Sclerosis 01/2017 - 04/2015
3	Ankylosing Spondylitis 03/2022 - 10/2015
3	Inflammation (Inflammations) 11/2021 - 10/2015
3	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2021 - 11/2013
3	Progressive Multifocal Leukoencephalopathy 01/2017 - 04/2015
2	COVID-19 07/2022 - 01/2022
2	Rheumatic Diseases (Rheumatism) 03/2022 - 07/2019
2	Psoriatic Arthritis 03/2022 - 02/2015
2	Necrosis 07/2019 - 01/2015
1	Fever (Fevers) 07/2022
1	Severe Acute Respiratory Syndrome 07/2022
1	Chronic Renal Insufficiency 01/2022
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2021
1	Tetanus 01/2018
1	Infections 01/2017
1	Hemophilia A (Haemophilia) 01/2017
1	Hypersensitivity (Allergy) 04/2009

7	AntibodiesIBA 07/2022 - 04/2009
4	Etanercept (Enbrel)FDA Link 03/2022 - 11/2013
4	Adalimumab (Humira)FDA Link 07/2019 - 11/2013
4	Natalizumab (Tysabri)FDA Link 01/2017 - 04/2015
2	Biological ProductsIBA 07/2022 - 07/2019
2	Antirheumatic Agents (DMARD)IBA 07/2022 - 02/2015
2	Immunoglobulin G (IgG)IBA 11/2021 - 04/2009
2	Pharmaceutical PreparationsIBA 04/2021 - 07/2019
2	Immunoglobulin E (IgE)IBA 01/2018 - 04/2009
1	COVID-19 VaccinesIBA 01/2022
1	acetyl 4-aminosalicylic acidIBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 11/2021
1	Anti-Citrullinated Protein AntibodiesIBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021
1	Tumor Necrosis Factor InhibitorsIBA 07/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2018
1	tocilizumab (atlizumab)FDA Link 03/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2017
1	Factor VIII (Coagulation Factor VIII)IBA 01/2017
1	LigandsIBA 10/2015
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2015
1	Ustekinumab (CNTO 1275)FDA Link 09/2015

1	Organ Transplantation 07/2022
1	Kidney Transplantation 01/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Biological Therapy 02/2021
1	Plasma Exchange 04/2015